Developments Dova Pharma subsidiary gets approval for thrombocytopenia drug in China Dova Pharmaceuticals’ (NASDAQ:DOVA) wholly-owned subsidiary, AkaRx, reported that the China National Medical Products Administration (NMPA) approved DOPTELET for the treatment of thrombocytopenia in adult patients with... April 30, 2020